These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Pruyn SC; Phelan JP; Buchanan GC Am J Obstet Gynecol; 1979 Oct; 135(4):485-9. PubMed ID: 573555 [TBL] [Abstract][Full Text] [Related]
6. Contemporary maternal and fetal outcomes in the treatment of LQTS during pregnancy: Is nadolol bad for the fetus? Hammond BH; El Assaad I; Herber JM; Saarel EV; Cantillon D; Aziz PF Heart Rhythm; 2022 Sep; 19(9):1516-1521. PubMed ID: 35525421 [TBL] [Abstract][Full Text] [Related]
7. Atenolol: side effects in the newborn infant. Thorley KJ Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1116. PubMed ID: 6812770 [No Abstract] [Full Text] [Related]
8. Effects of maternal labetalol on the newborn infant. Munshi UK; Deorari AK; Paul VK; Singh M Indian Pediatr; 1992 Dec; 29(12):1507-12. PubMed ID: 1291496 [TBL] [Abstract][Full Text] [Related]
9. Atenolol: side effects in a newborn infant. Br Med J (Clin Res Ed); 1982 Oct; 285(6346):972-3. PubMed ID: 6811094 [No Abstract] [Full Text] [Related]
10. Propranolol and hydrallazine in the management of essential hypertension in pregnancy. Bott-Kanner G; Schweitzer A; Reisner SH; Joel-Cohen SJ; Rosenfeld JB Br J Obstet Gynaecol; 1980 Feb; 87(2):110-4. PubMed ID: 7362797 [TBL] [Abstract][Full Text] [Related]
11. Atenolol: side effects in a newborn infant. Woods DL; Morrell DF Br Med J (Clin Res Ed); 1982 Sep; 285(6343):691-2. PubMed ID: 6809190 [No Abstract] [Full Text] [Related]
12. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol]. Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182 [No Abstract] [Full Text] [Related]
13. Atenolol in the treatment of essential hypertension during pregnancy. Rubin PC; Butters L; Low RA; Reid JL Br J Clin Pharmacol; 1982 Aug; 14(2):279-81. PubMed ID: 7104179 [TBL] [Abstract][Full Text] [Related]
14. [Beta-blockers and arterial hypertension in pregnancy]. Pontonnier G J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):830-5. PubMed ID: 6151959 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up. El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691 [TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Rubin PC; Butters L; Clark DM; Reynolds B; Sumner DJ; Steedman D; Low RA; Reid JL Lancet; 1983 Feb; 1(8322):431-4. PubMed ID: 6131164 [TBL] [Abstract][Full Text] [Related]
17. Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol. Shelley ED; Shelley WB Cutis; 1985 Feb; 35(2):148-9. PubMed ID: 3979099 [TBL] [Abstract][Full Text] [Related]
18. [Atenolol: its cardiorespiratory effects at birth in a premature infant]. Zanardo V; Trevisanuto D; Pellegrino PA; Cantarutti F Pediatr Med Chir; 1997; 19(3):149-51. PubMed ID: 9340604 [No Abstract] [Full Text] [Related]
19. Fetal hazards of altering hypotensive regimens in pregnancy. Nysenbaum A; McFarlane T; Gadd RL Br Med J; 1979 Aug; 2(6185):331-2. PubMed ID: 476447 [No Abstract] [Full Text] [Related]
20. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide]. Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]